Skip to main content

Media Category: x - Recorded Webinars

Managing Multiple Sclerosis in Individuals Aged 55 and Above.

Prof. Patrick Vermersch, from the University of Lille, delivered a compelling presentation at the Pre-MENACTRIMS Symposium, addressing the challenges of Managing Multiple Sclerosis in Individuals Aged 55 and Above. His session explored the impact of aging on MS progression, treatment responses, and practical management strategies for this growing patient demographic.“Managing Multiple Sclerosis in Individuals Aged 55 and Above“. Please subscribe to watch. Find out about the speaker:Prof. Patrick Vermersch

Continue reading

Pregnancy and Multiple Sclerosis: Safety Aspects and Treatment Modalities.

At the Pre-MENACTRIMS Symposium hosted by the ParadigMS Foundation, Prof. Celia Oreja-Guevara from Hospital Clínico San Carlos in Madrid presented an insightful lecture on Pregnancy and Multiple Sclerosis: Safety Aspects and Treatment Modalities. Her session focused on managing MS in women of reproductive age, addressing family planning, pregnancy, postpartum care, and the use of disease-modifying therapies (DMTs) in this population.“Pregnancy and Multiple Sclerosis: Safety Aspects and Treatment Modalities“. Please subscribe to watch. Find out about the speaker:Prof. Celia...

Continue reading

Epidemiology of Multiple Sclerosis in the Middle East and North Africa (MENA) region

As part of the Pre-MENACTRIMS Symposium hosted by ParadigMS Foundation, Professor Saeed Bohlega, Chairman of the Scientific Committee for MENACTRIMS, delivered a comprehensive lecture on the Epidemiology of Multiple Sclerosis (MS) in the Middle East and North Africa (MENA) region. The presentation provided a detailed overview of the increasing prevalence of MS in the region and explored key factors influencing these trends.“Epidemiology of Multiple Sclerosis in the MENA region”. Please subscribe to watch. About the Speaker: Prof. Saeed Bohlega Consultant Neurologist, Professor...

Continue reading

The use of generic, biosimilar and non-biologic complex drugs for multiple sclerosis

Key Takeaways​Generics, biosimilars, and NBCDs are designed to provide cost-effective alternatives to originator drugs. However, they require rigorous regulatory processes to ensure comparable efficacy and safety. Generics typically do not need clinical trials, while biosimilars must demonstrate similarity in structure, efficacy, and safety to the originator drug​. Studies show that biosimilars and generics are effective in managing multiple sclerosis (MS), with comparable safety and patient satisfaction. For example, follow-on therapies like fingolimod and biosimilar rituximab show similar...

Continue reading

MS therapies: what is in the Pipeline

BIOGRAPHY Nikolaos Grigoriadis Professor of Neurology at the Aristotle University of Thessaloniki Dr Nikolaos Grigoriadis graduated from the Faculty of Medicine of the Aristotle University of Thessaloniki. He did his PhD thesis and residency in Neurology in the same institution. He has been specialized in clinical and experimental Neuroimmunology and CNS immunopathology in a number of research centers and institutions abroad. He is now Professor of Neurology at the Aristotle University of Thessaloniki and Head of the of the B’ Dept of Neurology, AHEPA University Hospital, the MS Centre and...

Continue reading

AHSCT (Autologous Hematopoietic Stem Cell Transplantation) in MS – Update 

BIOGRAPHY  Magd Zakaria Head of the Multiple Sclerosis Unit at the Ain Shams Specialized University Hospital. Magd Zakaria obtained his medical degree from the Medical School of Ain Shams University in 1980 where he graduated with honors. He completed his residency and obtained his Master’s Degree in Neuropsychiatry at the Neuropsychiatric Department of Ain Shams University in 1984. Prof. Zakaria became Assistant Lecturer in 1989 and thereafter obtaining his MD degree in Neurology in 1989. Prof. Zakaria became Assistant Professor of Neurology in 1994 and Professor of Neurology since 1999 until...

Continue reading

FAQs

Is ParadigMS for free?

Yes, a ParadigMS subscription is free for healthcare practitioniers. 

Do subscriptions auto-renew?
Your subscription will automatically renew on yearly basis. If you cancel your plan, it will not renew at the end of your subscription cycle. 
I am a representative from industry, can I subscribe?

Free subscriptions to ParadigMS are reserved for healthcare practitioners. If you are a representative of the industry please contact us on learning@paradigms.foundation and we would advise you how to get the access to the material. 

What happens if I subscribe as a HCP if I am not?
If you subscribe as a healthcare practitioner and it is proven that you are not a healthcare practitioner, we will cancel your subscription immediately. 
I am a patient, can I subscribe?

ParadigMS is designed specifically for healthcare practitioners, with content and language tailored to their professional needs. While patients cannot subscribe directly, we encourage you to consult your healthcare provider for relevant insights and updates that may benefit you.

Why should I subscribe to ParadigMS's e-platform?

Subscribing to ParadigMS’s e-platform gives you access to up-to-date information and valuable learning materials on multiple sclerosis and NMO, along with expert insights and the latest innovations in the field. It’s an essential resource for staying informed and enhancing your knowledge in MS care.

How can I cancel my subscription?
You can cancel your subscription in your account settings. 
Can I financially support ParadigMS?

Yes, you can financially support ParadigMS! We welcome donations to help us continue our mission of advancing multiple sclerosis education and research. Your contribution directly supports the creation of educational resources, expert discussions, and innovative projects in MS care. Visit our donation page to learn more about how you can make a difference: ParadigMS Donate.